Swiss Cure Pharma
Who We Are
Swiss Cure Pharma, a pivotal arm of the Swiss Group of Companies, stands as one of Switzerland's most expansive and diverse conglomerates. Founded in 2011 by Mr. Simon Morten, the company was born out of the recognition that the unique challenges faced by developing tropical countries were largely overlooked by the global scientific and organizational community.
Additionally, a glaring gap in local expertise to tackle these issues was identified. Hence, the core missions of Swiss Cure Pharma have remained consistent over the years: to enhance human and animal health and to utilize and conserve natural resources, particularly arthropods, more effectively.
Leveraging its deep zoological knowledge, Swiss Cure Pharma stands as an autonomous firm engaged in the acquisition and distribution of superior venoms and toxins.
Swiss Cure Pharma, a pivotal arm of the Swiss Group of Companies, stands as one of Switzerland's most expansive and diverse conglomerates. Founded in 2011 by Mr. Simon Morten, the company was born out of the recognition that the unique challenges faced by developing tropical countries were largely overlooked by the global scientific and organizational community.
Additionally, a glaring gap in local expertise to tackle these issues was identified. Hence, the core missions of Swiss Cure Pharma have remained consistent over the years: to enhance human and animal health and to utilize and conserve natural resources, particularly arthropods, more effectively.
Leveraging its deep zoological knowledge, Swiss Cure Pharma stands as an autonomous firm engaged in the acquisition and distribution of superior venoms and toxins.
Established in 2011, Swiss Cure Pharma has risen to prominence as a principal supplier in this specialized market, serving pharmaceutical corporations, medical research institutions, and drug development teams worldwide.
The procurement of venoms is executed under rigorous conditions, sourcing from animals gathered across the globe or raised in our proprietary breeding centers. Through partnerships with forefront research organizations, we generate refined toxins, botanical extracts, and various pharmacological substances, each provided with comprehensive technical details regarding their purity and biological efficacy.
Swiss Cure Pharma's commitment to unparalleled quality and dependability ensures our offerings significantly enhance the accuracy of scientific research, a pledge reinforced by consistent audits conducted by leading pharmaceutical entities.
Established in 2011, Swiss Cure Pharma has risen to prominence as a principal supplier in this specialized market, serving pharmaceutical corporations, medical research institutions, and drug development teams worldwide.
The procurement of venoms is executed under rigorous conditions, sourcing from animals gathered across the globe or raised in our proprietary breeding centers. Through partnerships with forefront research organizations, we generate refined toxins, botanical extracts, and various pharmacological substances, each provided with comprehensive technical details regarding their purity and biological efficacy.
Swiss Cure Pharma's commitment to unparalleled quality and dependability ensures our offerings significantly enhance the accuracy of scientific research, a pledge reinforced by consistent audits conducted by leading pharmaceutical entities.
